Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Jounce Therapeutics, Inc. (JNCE) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/15/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
05/05/2023 4 Concentra Biosciences, LLC (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Acquired 10,000 shares @ $9737.7, valued at $97.4M
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
05/05/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/04/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Kamen Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Unknown transaction of 60,975 shares @ $0
Unknown transaction of 33,875 shares @ $0
Disposed/sold 10,840 options to buy @ $9.56, valued at $103.6k
Disposed/sold 13,550 options to buy @ $7.92, valued at $107.3k
Disposed/sold 15,700 options to buy @ $4.46, valued at $70k
Disposed/sold 15,700 options to buy @ $7.58, valued at $119k
Disposed/sold 15,700 options to buy @ $7.27, valued at $114.1k
Disposed/sold 20,000 options to buy @ $2.8, valued at $56k
05/04/2023 4 Iannone Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Disposed/sold 31,400 options to buy @ $7.19, valued at $225.8k
Disposed/sold 7,850 options to buy @ $7.58, valued at $59.5k
Disposed/sold 15,700 options to buy @ $7.27, valued at $114.1k
Disposed/sold 20,000 options to buy @ $2.8, valued at $56k
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Diaz Luis (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Disposed/sold 27,100 options to buy @ $14.78, valued at $400.5k
Disposed/sold 10,163 options to buy @ $7.92, valued at $80.5k
Disposed/sold 15,700 options to buy @ $4.46, valued at $70k
Disposed/sold 15,700 options to buy @ $7.58, valued at $119k
Disposed/sold 15,700 options to buy @ $7.27, valued at $114.1k
Disposed/sold 20,000 options to buy @ $2.8, valued at $56k
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/04/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/04/2023 8-K Quarterly results
05/04/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/04/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/28/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/25/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/24/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/06/2023 4 MURRAY RICHARD /CA/ (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 39,228 shares @ $1.85, valued at $72.6k
04/06/2023 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy